Search

everythinglearnresearchcommunity

for

Search:↓

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Treating underlying metabolic and hormonal issues is key to managing female hair loss.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Elephantopus scaber has many health benefits, including antibacterial, antifungal, anticancer, and antioxidant properties.

Higher doses of isotretinoin may lead to more hair loss.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

People with lichen planus are more likely to have abnormal blood fats than healthy people.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Skin tags in obese individuals may indicate higher cardiovascular risk.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Biotin supplements are unnecessary for most people but may help with certain conditions like biotin deficiency, brittle nails, and some hair loss.